Meads, M. B., Zhao, X., Noyes, D., Sudalagunta, P. R., Achille, A., Zhang, C., Canevarolo, R. R., Silva, M., Magaletti, D., DeAvila, D., Toska, S., Oates, A., Lastorino, D., Idiaquez, D. W., Song, J., Sansil, S. S., Yoder, S. J., Grajales-Cruz, A. F., Blue, B., Freeman, C. L., Kim, J., Alsina, M., Brayer, J., Silva, A. S., Song, X., Shain, K. H., Baz, R. (2026). Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy. Blood. https://doi.org/10.1182/blood.2025029921